Rep. Waxman Statement on the Supreme Court Ruling in Caraco v. Novo

Apr 17, 2012

Ranking Member Henry A. Waxman released the following statement in response to the Supreme Court’s decision in the Caraco Pharmaceutical v. Novo Nordisk case:

“I welcome the decision by the U.S. Supreme Court on the Caraco v. Novo case. While the issues in the case may seem arcane, the fact of the matter is that allowing brand companies to exaggerate the breadth of their patent protections in their listings with FDA served as a real block to generics. I am pleased that the courts unanimously agreed with that view. This decision is in the interest of American consumers who should have the benefit of competition and lower prices.”

Rep. Waxman filed an amicus brief with the Court in September 2011 that is posted below.

Recent News


Ranking Member Waxman Urges a No Vote on H.R. 3, Calls for Opposition to Keystone XL Tar Sands Pipeline 05/22/2013
Markey, Waxman Report Highlights Gaps in Grid Security 05/21/2013
Rep. Waxman Urges No Vote on H.R. 3: Bill Tramples on U.S. Law to Give Regulatory Earmark 05/21/2013
Ranking Member Waxman Releases New Analysis of Proposed ACA Insurance Rates 05/20/2013
Leading Energy and Commerce Democrats Clarify Congressional Intent of Spectrum Provisions, Urge Serious Consideration of DOJ Views 05/16/2013
Rep. Waxman Releases Report on State by State Impact of Repealing the Affordable Care Act 05/15/2013
Rep. Waxman Lauds Covered California Awards to Community Organization for Affordable Care Act Outreach and Education 05/14/2013
Committee Democrats Release Memorandum Criticizing Republican Staff Report on Impact of the Affordable Care Act 05/13/2013
Committee Releases White Paper Examining Environmental Impacts of Renewable Fuel Standard 05/09/2013
Rep. Waxman and Sen. Whitehouse Urge EPA to Reconsider Decision Not to Regulate Methane Emissions from Coal Mines 05/07/2013